Further to Imagion Biosystems Limited’s announcement dated 23 May 2018, the Company advises of an amendment to Resolution 9 of its Notice of Annual General Meeting dated 2 May 2018, which is detailed in the attached Notice of Amendment.
Save for as detailed in the Notice of Amendment, which will shortly be despatched to shareholders, all other aspects of the Notice of Annual General Meeting remain unchanged.
The Company’s Annual General Meeting will be held at 1.30pm (AEST) on Thursday, 31 May 2018 at the offices of Holding Redlich, Level 8, 555 Bourke Street, Melbourne, Victoria 3000.
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal